Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Fujian Medical University
Thomas Jefferson University
City of Hope Medical Center
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
Sumitomo Pharma America, Inc.
Chinese University of Hong Kong
Corewell Health West
University Hospital Heidelberg
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Gilead Sciences
University of California, Davis
Array BioPharma
Therapeutic Advances in Childhood Leukemia Consortium
University of Arizona
M.D. Anderson Cancer Center
Swiss Cancer Institute
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)
Memorial Sloan Kettering Cancer Center
Stanford University
Dartmouth-Hitchcock Medical Center
Indiana University
Novartis
National Cancer Institute (NCI)
Virginia Commonwealth University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
European Myeloma Network B.V.
Dana-Farber Cancer Institute
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
Case Comprehensive Cancer Center
Janssen-Cilag B.V.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Janssen-Cilag B.V.
Ohio State University Comprehensive Cancer Center